How prifetrastat is absorbed in healthy adults
This study tests how different forms of the study medicine prifetrastat enter the blood. It may help researchers understand the best way to give the medicine in future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult aged 18 or older.
- You are a woman who cannot become pregnant or a man.
- Your body mass index (BMI) is between 18 and 32, and you weigh more than 110 pounds (50 kg).
- You have not taken any prescription or over-the-counter drugs, vitamins, or herbal supplements for at least 14 days before the study starts.
- You have not used medicines that change certain liver enzymes (CYP2C9 or CYP3A4) for at least 14 days before the study, and you can avoid them during the study.
- You have stopped taking proton pump inhibitors (like omeprazole) at least 14 days before the study and will not take them during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the drug prifetrastat is absorbed into the blood when taken with or without food. You might be able to join if you are a generally healthy adult who is not taking other medications.
This early-stage study tests how a new experimental medicine moves through and leaves the body in healthy volunteers. Researchers will compare different forms of the medicine to understand which works best and is safest.
This trial tests a new drug, prifetrastat, combined with the hormone therapy fulvestrant for people with a type of breast cancer called HR+ (hormone receptor positive) and HER2- (HER2 negative) that has spread to other parts of the body. The goal is to see if this combination can help when previous treatments, including a CDK4/6 inhibitor and hormone therapy, have stopped working.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
This study compares two forms of an experimental drug called vonafexor to see how they work in the body and if they interact with other medications. It's for healthy volunteers to make sure the drug is safe before testing in patients with liver disease.
This study is for healthy men to see how the body processes an investigational drug called ASP3082. It is a first-in-human study, meaning it's one of the first times the drug is given to people, and the results will guide future research.
Hear when a new Healthy Participant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.